Search research articles
Contact Us
Filters
Showing results (91-100 of 376) with videos related to
Page
of 38
Sort By:
European Journal of Clinical Pharmacology
|
June 14, 2015
Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients
Nicolas Simon, Jonathan Finzi, Guillaume Cayla, et al.
Circulation
|
October 1, 2003
Images in cardiovascular medicine. Recurrent myocardial infarction in a patient with paroxysmal nocturnal hemoglobinuria
Fabien Hyafil, Gilles Montalescot, Zahir Amoura, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Dual antiplatelet therapy: optimal timing, management, and duration
Pierre Sabouret, Sophie K Rushton-Smith, Mathieu Kerneis, et al.
European Heart Journal
|
August 30, 2020
Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Emanuele Barbato, Julinda Mehilli, Dirk Sibbing, et al.
Thrombosis and Haemostasis
|
December 30, 2022
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation
Freek W A Verheugt, Kurt Huber, Peter Clemmensen, et al.
Current Pharmaceutical Design
|
June 26, 2012
Pharmacogenetics of clopidogrel
Stephen A O'Connor, Jean-Sebastien Hulot, Johanne Silvain, et al.
Journal of Clinical Medicine
|
June 2, 2021
Inappropriate Use of Oral Antithrombotic Combinations in an Outpatient Setting and Associated Risks: A French Nationwide Cohort Study
Lorène Zerah, Dominique Bonnet-Zamponi, Aya Ajrouche, et al.
Plos One
|
February 15, 2019
A prescription support-tool for chronic management of oral antithrombotic combinations in adults based on a systematic review of international guidelines
Lorene Zerah, René-Sosata Bun, Sylvie Guillo, et al.
American Heart Journal
|
December 21, 2010
Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study
Jean-Philippe Collet, Guillaume Cayla, Thomas Cuisset, et al.
The American Journal of Cardiology
|
November 3, 2012
Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis
Benjamin Terrier, Alexandre Karras, Philippe Cluzel, et al.
Page
of 38
Search research articles
Search
Showing results (91-100 of 376) with videos related to
Sort By:
Page
of 38
European Journal of Clinical Pharmacology
|
June 14, 2015
Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients
Nicolas Simon, Jonathan Finzi, Guillaume Cayla, et al.
Circulation
|
October 1, 2003
Images in cardiovascular medicine. Recurrent myocardial infarction in a patient with paroxysmal nocturnal hemoglobinuria
Fabien Hyafil, Gilles Montalescot, Zahir Amoura, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Dual antiplatelet therapy: optimal timing, management, and duration
Pierre Sabouret, Sophie K Rushton-Smith, Mathieu Kerneis, et al.
European Heart Journal
|
August 30, 2020
Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Emanuele Barbato, Julinda Mehilli, Dirk Sibbing, et al.
Thrombosis and Haemostasis
|
December 30, 2022
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation
Freek W A Verheugt, Kurt Huber, Peter Clemmensen, et al.
Current Pharmaceutical Design
|
June 26, 2012
Pharmacogenetics of clopidogrel
Stephen A O'Connor, Jean-Sebastien Hulot, Johanne Silvain, et al.
Journal of Clinical Medicine
|
June 2, 2021
Inappropriate Use of Oral Antithrombotic Combinations in an Outpatient Setting and Associated Risks: A French Nationwide Cohort Study
Lorène Zerah, Dominique Bonnet-Zamponi, Aya Ajrouche, et al.
Plos One
|
February 15, 2019
A prescription support-tool for chronic management of oral antithrombotic combinations in adults based on a systematic review of international guidelines
Lorene Zerah, René-Sosata Bun, Sylvie Guillo, et al.
American Heart Journal
|
December 21, 2010
Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study
Jean-Philippe Collet, Guillaume Cayla, Thomas Cuisset, et al.
The American Journal of Cardiology
|
November 3, 2012
Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis
Benjamin Terrier, Alexandre Karras, Philippe Cluzel, et al.
Page
of 38